These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24559750)

  • 1. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
    Sheng RF; Zeng MS; Rao SX; Ji Y; Chen LL
    Clin Imaging; 2014; 38(3):265-72. PubMed ID: 24559750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings.
    Liu QY; Huang SQ; Chen JY; Li HG; Gao M; Liu C; Liang BL
    Abdom Imaging; 2010 Oct; 35(5):537-42. PubMed ID: 19763681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
    Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
    J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
    Choi SH; Lee SS; Kim SY; Park SH; Park SH; Kim KM; Hong SM; Yu E; Lee MG
    Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.
    Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS
    J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI.
    Kim YK; Han YM; Kim CS
    Eur J Radiol; 2009 Apr; 70(1):94-100. PubMed ID: 18316169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
    Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
    Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B; Wu L; Lu XY; Xu F; Liu CF; Shen WF; Jia NY; Cheng HY; Yang YF; Shen F
    Radiology; 2016 Oct; 281(1):150-7. PubMed ID: 27077381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
    Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
    Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.